| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30000739 | HIV | ENSG00000167286.12 | protein_coding | CD3D | No | No | 915 | B0YIY4 P04234 |
| TVIS30031392 | HIV | ENSG00000167286.12 | protein_coding | CD3D | No | No | 915 | B0YIY4 P04234 |
| TVIS44017284 | HTLV-1 | ENSG00000167286.12 | protein_coding | CD3D | No | No | 915 | B0YIY4 P04234 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CD3D |
|---|---|
| DrugBank ID | DB00075 |
| Drug Name | Muromonab |
| Target ID | BE0003456 |
| UniProt ID | P04234 |
| Regulation Type | |
| PubMed IDs | 2503348; 8861551 |
| Citations | Todd PA, Brogden RN: Muromonab CD3. A review of its pharmacology and therapeutic potential. Drugs. 1989 Jun;37(6):871-99.@@Wilde MI, Goa KL: Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection. Drugs. 1996 May;51(5):865-94. |
| Groups | Approved; Investigational |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | |
| PharmGKB | PA164743097 |
| ChEMBL | CHEMBL1201608 |
